Inventor · disambiguated record
Matthew Whitters
Also filed as: WHITTERS MATTHEW · WHITTERS MATTHEW J · WHITTERS MATTHEW JAMES
17 granted patents·10 pending applications·851 citations·filing 1996–2010
96Inventor score
Top patents by PatentIndex Score
27 records- 0196US5710023AIL-13 cytokine receptor chainGENETICS INST·Filed 1996·Granted Jan 20, 1998·131 cites·21 claims
- 0295US7618632B2Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodiesWYETH CORP·Filed 2004·Granted Nov 17, 2009·326 cites·4 claims
- 0394US7078494B1Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 bindingGENETICS INST LLC·Filed 2000·Granted Jul 18, 2006·43 cites·29 claims
- 0490US7674591B2Methods of using antibodies to human IL-13bc for inhibiting IL-13 bindingGENETICS INST LLC·Filed 2006·Granted Mar 9, 2010·8 cites·31 claims
- 0590US7553487B2Method and compositions for treating asthmaGENETICS INST LLC·Filed 2004·Granted Jun 30, 2009·36 cites·25 claims
- 0689US7731946B2Methods and compositions for modulating T helper (TH) cell development and functionWYETH LLC·Filed 2007·Granted Jun 8, 2010·17 cites·10 claims
- 0787US7495085B2Antibodies against human or mouse IL-21 receptorWYETH CORP·Filed 2004·Granted Feb 24, 2009·26 cites·18 claims
- 0887US7314623B2Methods and compositions for modulating T helper (Th) cell development and functionWYETH CORP·Filed 2003·Granted Jan 1, 2008·32 cites·11 claims
- 0987US7282206B2Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chainsUS HEALTH·Filed 2003·Granted Oct 16, 2007·24 cites·34 claims
- 1086US7198789B2Methods and compositions for modulating interleukin-21 receptor activityGENETICS INST LLC·Filed 2002·Granted Apr 3, 2007·32 cites·66 claims
- 1186US6664227B1Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chainsINST GENETICS LLC·Filed 1999·Granted Dec 16, 2003·61 cites·32 claims
- 1284US7189400B2Methods of treatment with antagonists of MU-1GENETICS INST LLC·Filed 2001·Granted Mar 13, 2007·20 cites·38 claims
- 1384US6214559B1Methods of identifying inhibitors of binding of IL-13 to the IL-13 receptor chainGENETICS INST·Filed 1997·Granted Apr 10, 2001·32 cites·5 claims
- 1482US8143385B2Nucleic acids coding for antibodies against human IL-21 receptor and uses thereforVALGE-ARCHER VIIA·Filed 2009·Granted Mar 27, 2012·8 cites·12 claims
- 1580US6268480B1IL-13 Receptor chainGENETICS INST·Filed 1997·Granted Jul 31, 2001·23 cites·15 claims
- 1680US6248714B1Methods of inhibiting binding and treating Ig-mediated responses with IL-13 receptorGENETICS INST·Filed 1997·Granted Jun 19, 2001·25 cites·15 claims
- 1758US2010086516A1Cytokine receptor chainGENETICS INST LLC·Filed 2009·Application pending·0 cites
- 1857US2010080809A1Gitr ligand and gitr ligand-related molecules and antibodies and uses thereofWYETH CORP·Filed 2009·Application pending·0 cites
- 1955US2008241098A1Antagonizing interleukin-21 receptor activityWYETH CORP·Filed 2007·Application pending·0 cites
- 2055US2008221016A1Cd25+ differential markers and uses thereofWYETH CORP·Filed 2008·Application pending·0 cites
- 2152US2003133936A1CD25markers and uses thereofFiled 2002·Application pending·0 cites
- 2248US7507706B1Cytokine receptor chainGENETICS INST LLC·Filed 1999·Granted Mar 24, 2009·7 cites·23 claims
- 2347US2006039902A1Antagonizing interleukin-21 receptor activityYOUNG DEBORAH A·Filed 2005·Application pending·0 cites
- 2446US2004016010A1IL-21 receptor knockout animal and methods of use thereofFiled 2003·Application pending·0 cites
- 2544US2010223685A1Il-21 receptor knockout animal and methods of use thereofKASAIAN MARION·Filed 2010·Application pending·0 cites
- 2644US2009022731A1Arthritis-associated B cell gene expressionWYETH CORP·Filed 2007·Application pending·0 cites
- 2742US2003086932A1Surface-bound antigen binding portions of antibodies that bind to CTLA-4 and CD28 and uses thereforFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Whitters files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →